CDKN1C and pancreatic adenocarcinoma: In pancreatic adenocarcinoma, the synergism was ascribed to several interacting mechanisms, encompassing inhibition of AKT signaling, increased STAT3 phosphorylation, and prominent induction of the CDK inhibitor p57KIP2 [8].